COMMUNIQUÉ DE PRESSE publié le 29/02/2024 à 22:05, il y a 2 années Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers Sonnet BioTherapeutics Holdings, Inc. announced the publication of clinical data on SON-1010, a tumor-targeted immunotherapeutic drug combining FHAB construct with IL-12 in Frontiers in Immunology, showing favorable safety and tolerability Clinical Data Sonnet BioTherapeutics SON-1010 Immunotherapeutic Drug FHAB Technology
COMMUNIQUÉ DE PRESSE publié le 14/02/2024 à 13:30, il y a 2 années 1 mois Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update Sonnet BioTherapeutics Holdings, Inc. successfully raised $4.55 million, published preclinical data on SON-1210, executed NJ NOLs agreement, Phase 1b SON-080 trial enrollment completed, financial results announced for quarter ended Dec 31, 2023 Financial Results Preclinical Data Public Offering Sonnet BioTherapeutics Holdings NJ NOLs
COMMUNIQUÉ DE PRESSE publié le 21/12/2023 à 14:00, il y a 2 années 3 mois Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
COMMUNIQUÉ DE PRESSE publié le 14/12/2023 à 22:15, il y a 2 années 3 mois Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
COMMUNIQUÉ DE PRESSE publié le 31/10/2023 à 12:30, il y a 2 années 4 mois Sonnet BioTherapeutics Provides Fiscal Year 2023 Business Overview
COMMUNIQUÉ DE PRESSE publié le 25/10/2023 à 13:30, il y a 2 années 4 mois Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
COMMUNIQUÉ DE PRESSE publié le 17/10/2023 à 14:00, il y a 2 années 5 mois Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
COMMUNIQUÉ DE PRESSE publié le 20/09/2023 à 13:30, il y a 2 années 6 mois Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology
Publié le 23/03/2026 à 19:08, il y a 11 heures 14 minutes Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Publié le 23/03/2026 à 19:08, il y a 11 heures 14 minutes Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Publié le 23/03/2026 à 18:37, il y a 11 heures 45 minutes ALTAREA : Déclaration d’opérations sur actions propres
Publié le 23/03/2026 à 17:45, il y a 12 heures 37 minutes ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Publié le 23/03/2026 à 17:45, il y a 12 heures 37 minutes En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde
Publié le 23/03/2026 à 22:40, il y a 7 heures 42 minutes Troubadour Announces Withdrawal of Non-Brokered Private Placements
Publié le 23/03/2026 à 22:30, il y a 7 heures 52 minutes Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Publié le 23/03/2026 à 22:00, il y a 8 heures 22 minutes Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Publié le 23/03/2026 à 21:18, il y a 9 heures 4 minutes Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Publié le 24/03/2026 à 06:00, il y a 22 minutes 51st Annual General Meeting of BELIMO Holding AG Approves All Motions
Publié le 24/03/2026 à 06:00, il y a 22 minutes SKAN with good order intake in the 2025 financial year
Publié le 24/03/2026 à 05:10, il y a 1 heure 12 minutes Huawei Releases the NG WAN White Paper to Fully Upgrade IP Bearer Networks and Drive New Growth for Carriers
Publié le 24/03/2026 à 02:00, il y a 4 heures 22 minutes Discover a season of arts and sports mega events in Hong Kong
Publié le 24/03/2026 à 00:55, il y a 5 heures 27 minutes mymediset Introduces Agentic AI for MedTech Supply Chains at LogiMed 2026